Coronavirus vaccine ‘Covaxin’ enters phase-3 Trials.

The COVID-19 vaccine, Covaxin, being developed by Bharat Biotech is now undergoing phase-3 trials, Krishna Ella, Chairman and Managing Director, Bharat Biotech said on Monday.

“We partnered with ICMR for COVID-19 vaccine as we speak it entered the phase 3 trials,” he said.

The company is also working on another vaccine for COVID-19 which would be in the form of nasal drops and can be ready by next year, says Chairman and Managing Director.

Bharat Biotech is the only vaccine company in the world which has BSL3 production facility (Biosafety level 3), he said.